Medicare Enrolled
Dr. Asif Lakhani, M.D.
Internal Medicine · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lakhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lakhani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lakhani
Dr. Asif Lakhani is an internal medicine specialist in Webster, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lakhani performed 74,153 Medicare services across 1,862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lakhani received a total of $2,400 from 48 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lakhani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 1% volume in TX
$2,400 industry payments
Medicare Practice Summary
Medicare Utilization ↗74,153
Medicare services
Top 1% in TX for internal medicine
1,862
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,944 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,460 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 11,100 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,900 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,025 | $2 | $20 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
6,200 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,581 | $0 | $3 |
| Paclitaxel chemotherapy injection | 3,794 | $0 | $8 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,353 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 970 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 578 | $3 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
566 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
539 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
519 | $10 | $64 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
409 | $2 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
357 | $92 | $368 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
312 | $23 | $157 |
| Injection, granisetron hydrochloride, 100 mcg | 270 | $0 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
220 | $104 | $707 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
206 | $2 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
177 | $94 | $357 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
168 | $137 | $496 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
157 | $61 | $247 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
147 | $12 | $108 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
108 | $51 | $313 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
104 | $11 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
97 | $23 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
94 | $52 | $344 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
73 | $7 | $431 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
65 | $1 | $7 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
61 | $58 | $211 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
55 | $137 | $694 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
50 | $35 | $143 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
47 | $52 | $821 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
45 | $1,186 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 44 | $91 | $657 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
44 | $135 | $500 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
41 | $185 | $1,067 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $8 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
32 | $16 | $94 |
| New patient office visit, complex (60-74 min) | 28 | $170 | $709 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
24 | $47 | $686 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
18 | $18 | $114 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
17 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
17 | $6 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $127 | $565 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
14 | $2 | $19 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
11 | $80 | $560 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.7% high complexity
63.6% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,400
Total received (2018-2024)
Avg $400/year across 6 years
Top 27% in TX for internal medicine
48
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,214 (92.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$186 (7.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$752
2023
$803
2022
$607
2021
$24
2019
$113
2018
$100
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$192
Novartis Pharmaceuticals Corporation
$173
Janssen Biotech, Inc.
$153
Apellis Pharmaceuticals, Inc.
$143
Incyte Corporation
$114
PFIZER INC.
$90
EMD Serono, Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$78
JAZZ PHARMACEUTICALS INC.
$62
Merck Sharp & Dohme LLC
$58
Daiichi Sankyo Inc.
$56
GENZYME CORPORATION
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
ABBVIE INC.
$51
Sobi, Inc
$51
Mirati Therapeutics, Inc.
$51
Gilead Sciences, Inc.
$51
Seagen Inc.
$50
BeiGene USA, Inc.
$49
Rigel Pharmaceuticals, Inc.
$46
Eisai Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
AstraZeneca Pharmaceuticals LP
$42
MorphoSys, US Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$36
Sirtex Medical Inc
$36
Celgene Corporation
$34
CTI BioPharma Corp.
$33
PharmaEssentia USA Corporation
$32
Myovant Sciences Inc.
$28
TerSera Therapeutics LLC
$28
Genentech USA, Inc.
$27
SOBI, INC
$26
Deciphera Pharmaceuticals Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Stemline Therapeutics Inc.
$23
TAIHO ONCOLOGY, INC.
$22
Karyopharm Therapeutics Inc.
$21
Puma Biotechnology, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Tactile Systems Technology Inc
$19
E.R. Squibb & Sons, L.L.C.
$19
Exelixis Inc.
$18
Amgen Inc.
$16
ARRAY BIOPHARMA INC
$15
Alnylam Pharmaceuticals Inc.
$14
Myriad Genetic Laboratories, Inc.
$12
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Alecensa · BAVENCIO · BESPONSA · BESREMI · BRUKINSA · CABOMETYX · DARZALEX · DOPTELET · Doptelet · ELAHERE · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Fabhalta · Flexitouch Plus · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LONSURF · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · OPDIVO · ORGOVYX · Orserdu · PIQRAY · PROMACTA · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TUKYSA · Trodelvy · ULTOMIRIS · VERZENIO · Vonjo · XALKORI · XPOVIO · XTANDI · Xofigo · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
1,900
Per 100K population
39.9
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lakhani is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lakhani experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lakhani performed 23,460 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lakhani receive payments from pharmaceutical companies?
Yes. Dr. Lakhani received a total of $2,400 from 48 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lakhani's costs compare to other internal medicine physicians in Webster?
Dr. Lakhani's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lakhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Webster
Browse internal medicine physicians in Webster ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology